US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ENGENE HOLDINGS INC

3.83

+0.04001.06%

Post-market: 3.830.00000.00%16:04 EDT

Volume:91.11K

Turnover:345.89K

Market Cap:195.73M

PE:-2.29

High:3.96

Open:3.74

Low:3.67

Close:3.79

Loading ...

Overview Company News Filings

enGene Holdings Inc. Files Initial Statement of Beneficial Ownership for Chief Regulatory Officer Matthew Ross Boyd

enGene Holdings Inc. Files Initial Beneficial Ownership Statement for Chief Development Officer Jill Buck

enGene Holdings Inc. Announces New Board Members and Leadership Promotions to Drive Commercialization Efforts

Wells Fargo Reaffirms Their Buy Rating on enGene Holdings (ENGN)

FDA Grants RMAT Designation to enGene's Detalimogene for Expedited Review in High-Risk Bladder Cancer

Analysts Offer Insights on Real Estate Companies: CareTrust REIT (CTRE) and enGene Holdings (ENGN)

enGene Holdings Inc. Announces Inducement Equity Awards for New Employees Under NASDAQ Rule 5635(c)(4)

Analysts Offer Insights on Real Estate Companies: Federal Realty (FRT) and enGene Holdings (ENGN)

Raymond James Remains a Buy on enGene Holdings (ENGN)

BRIEF-enGene Reports Second Quarter 2025 Financial Results And Provides Business Update

enGene Holdings Q2 EPS $(0.51) Misses $(0.49) Estimate

enGene Holdings Reports Q2 2025 Net Loss of $25.8M, EPS at $0.51, Up from $15.0M Loss, EPS $0.38 in Q2 2024

Press Release: enGene Reports Second Quarter 2025 Financial Results and Provides Business Update

Calendar of U.S. Earnings Expected in the Week Ahead

enGene Holdings Inc. Conducted Annual General Meeting

Calendar of U.S. Earnings Expected in the Week Ahead

enGene Holdings Inc expected to post a loss of 50 cents a share - Earnings Preview

enGene Holdings Inc. Announces Resignation of Chief Medical Officer Dr. Raj Pruthi, Effective June 16, 2025

enGene Holdings Inc. Files Initial Statement of Beneficial Ownership for Chief Global Communications Officer Amy Pott

enGene Holdings Inc. to Present at Jefferies Global Healthcare Conference in New York City

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ENGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ENGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENGN\",,,,,undefined,":{"symbol":"ENGN","market":"US","secType":"STK","nameCN":"ENGENE HOLDINGS INC","latestPrice":3.83,"timestamp":1754078400000,"preClose":3.79,"halted":0,"volume":91106,"hourTrading":{"tag":"盘后","latestPrice":3.83,"preClose":3.83,"latestTime":"16:04 EDT","volume":4,"amount":15.32,"timestamp":1754078656666},"delay":0,"floatShares":26039336,"shares":51105201,"eps":-1.675004,"marketStatus":"Market Closed","change":0.04,"latestTime":"08-01 16:00:00 EDT","open":3.74,"high":3.96,"low":3.67,"amount":345892.5925,"amplitude":0.076517,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.675004,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":3.79,"dividendRate":0.000261,"preHourTrading":{"tag":"盘前","latestPrice":3.8,"preClose":3.79,"latestTime":"09:28 EDT","volume":552,"amount":2100.6399744,"timestamp":1754054880054},"postHourTrading":{"tag":"盘后","latestPrice":3.83,"preClose":3.83,"latestTime":"16:04 EDT","volume":4,"amount":15.32,"timestamp":1754078656666},"volumeRatio":0.4308394524642982},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENGN\",,,,,undefined,":{"symbol":"ENGN","floatShares":26039336,"roa":"-20.35%","roe":"-33.97%","lyrEps":-1.459464,"volumeRatio":0.4308394524642982,"shares":51105201,"dividePrice":0.001,"high":3.96,"amplitude":0.076517,"preClose":3.79,"low":3.67,"week52Low":2.65,"pbRate":"0.86","week52High":11,"institutionHeld":0,"latestPrice":3.83,"eps":-1.675004,"divideRate":0.000261,"volume":91106,"delay":0,"ttmEps":-1.675004,"open":3.74,"prevYearClose":6.65,"prevWeekClose":3.7,"prevMonthClose":3.79,"prevQuarterClose":3.64,"fiveDayClose":3.7,"twentyDayClose":3.8,"sixtyDayClose":3.69},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2551135133","title":"enGene Holdings Inc. Files Initial Statement of Beneficial Ownership for Chief Regulatory Officer Matthew Ross Boyd","url":"https://stock-news.laohu8.com/highlight/detail?id=2551135133","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551135133?lang=en_us&edition=fundamental","pubTime":"2025-07-15 04:09","pubTimestamp":1752523782,"startTime":"0","endTime":"0","summary":"enGene Holdings Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing lists Matthew Ross Boyd as the beneficial owner, serving as the Chief Regulatory Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDL9kxMY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2550578251","title":"enGene Holdings Inc. Files Initial Beneficial Ownership Statement for Chief Development Officer Jill Buck","url":"https://stock-news.laohu8.com/highlight/detail?id=2550578251","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550578251?lang=en_us&edition=fundamental","pubTime":"2025-07-09 04:09","pubTimestamp":1752005356,"startTime":"0","endTime":"0","summary":"enGene Holdings Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing reports Jill Buck as the beneficial owner, who serves as the Chief Development Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 08, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDL8Yr4C8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2549544925","title":"enGene Holdings Inc. Announces New Board Members and Leadership Promotions to Drive Commercialization Efforts","url":"https://stock-news.laohu8.com/highlight/detail?id=2549544925","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549544925?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:01","pubTimestamp":1751976066,"startTime":"0","endTime":"0","summary":"enGene Holdings Inc. has announced new appointments to its Board and management team to support its commercial readiness. Philip Astley-Sparke, William Grossman, and Michael Heffernan have joined the Board of Directors. Additionally, Matthew Boyd has been promoted to Chief Regulatory Officer, Jill Buck to Chief Development Officer, and Katherine Chan to Executive Director, Urology Clinical Lead. These changes are part of enGene's strategic transition towards the planned commercialization of its lead investigational therapy, detalimogene.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Holdings Inc. published the original content used to generate this news brief via Business Wire  on July 08, 2025, and is solely responsible for th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDL5fS5XH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2546789561","title":"Wells Fargo Reaffirms Their Buy Rating on enGene Holdings (ENGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2546789561","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546789561?lang=en_us&edition=fundamental","pubTime":"2025-06-26 17:55","pubTimestamp":1750931745,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Yanan Zhu maintained a Buy rating on enGene Holdings (ENGN – Research Report) yesterday and set a price target of $25.00. The c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wells-fargo-reaffirms-their-buy-rating-on-engene-holdings-engn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wells-fargo-reaffirms-their-buy-rating-on-engene-holdings-engn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENGN"],"gpt_icon":0},{"id":"2546921758","title":"FDA Grants RMAT Designation to enGene's Detalimogene for Expedited Review in High-Risk Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2546921758","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546921758?lang=en_us&edition=fundamental","pubTime":"2025-06-25 20:00","pubTimestamp":1750852830,"startTime":"0","endTime":"0","summary":"enGene Holdings Inc., a clinical-stage, non-viral gene-based immunotherapy company, has announced that its lead investigational therapy, detalimogene voraplasmid , has been granted Regenerative Medicine Advanced Therapy  designation by the U.S. Food and Drug Administration . This designation is aimed at expediting the development and review of therapies addressing serious conditions with unmet medical needs. The RMAT designation for detalimogene highlights its potential to treat high-risk, Bacillus Calmette-Guérin -unresponsive, non-muscle invasive bladder cancer  with carcinoma in situ . This provides enGene with regulatory advantages such as early engagement with the FDA and potential for priority and rolling review. The designation is based on preliminary results from the ongoing pivotal LEGEND study, showcasing promising clinical activity and tolerability. Detalimogene is designed for easy administration in urology clinics, offering a potentially transformative option for patients ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDL4rhcWZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2544995807","title":"Analysts Offer Insights on Real Estate Companies: CareTrust REIT (CTRE) and enGene Holdings (ENGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2544995807","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544995807?lang=en_us&edition=fundamental","pubTime":"2025-06-17 22:10","pubTimestamp":1750169407,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on CareTrust REIT (CTRE – Research Report) and enGene ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-caretrust-reit-ctre-and-engene-holdings-engn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-caretrust-reit-ctre-and-engene-holdings-engn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4225","BK4203","BK4139","ENGN","CTRE","REIT"],"gpt_icon":0},{"id":"2544962898","title":"enGene Holdings Inc. Announces Inducement Equity Awards for New Employees Under NASDAQ Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2544962898","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544962898?lang=en_us&edition=fundamental","pubTime":"2025-06-17 20:00","pubTimestamp":1750161649,"startTime":"0","endTime":"0","summary":"BOSTON & MONTREAL-- enGene Holdings Inc.  has announced the issuance of inducement equity awards to four newly-hired employees, including Chief Global Commercialization Officer Amy Pott, with a grant date of June 16, 2025. Ms. Pott received a non-qualified stock option to purchase 400,000 common shares, while the other three employees were granted options for a total of 53,450 shares. Each stock option, carrying an exercise price of $3.31 per share, has a 10-year term and vests over four years. The options were approved by the independent Compensation Committee of the Board of Directors under NASDAQ Listing Rule 5635.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Holdings Inc. published the original content used to generate thi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDL8mWn5N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2543825671","title":"Analysts Offer Insights on Real Estate Companies: Federal Realty (FRT) and enGene Holdings (ENGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2543825671","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543825671?lang=en_us&edition=fundamental","pubTime":"2025-06-16 19:00","pubTimestamp":1750071638,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on Federal Realty (FRT – Research Report) and enGene H...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-federal-realty-frt-and-engene-holdings-engn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-federal-realty-frt-and-engene-holdings-engn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","US7Y.BOND","FRT","BK4080","BK4585","US5Y.BOND","US3Y.BOND","ENGN","US10Y.BOND","US6M.BOND","US12M.BOND","BK4588","US30Y.BOND","US2Y.BOND","BK4231"],"gpt_icon":0},{"id":"2543682658","title":"Raymond James Remains a Buy on enGene Holdings (ENGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2543682658","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543682658?lang=en_us&edition=fundamental","pubTime":"2025-06-13 20:35","pubTimestamp":1749818137,"startTime":"0","endTime":"0","summary":"Raymond James analyst Sean McCutcheon reiterated a Buy rating on enGene Holdings (ENGN – Research Report) yesterday and set a price target of $23.0...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/raymond-james-remains-a-buy-on-engene-holdings-engn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/raymond-james-remains-a-buy-on-engene-holdings-engn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU1804176565.USD","ENGN","LU1363072403.SGD","BK4127","BK4139","IE00BGHQF748.EUR","LU2265009873.SGD","LU0971096721.USD","BK4588","RJF","BK4585"],"gpt_icon":0},{"id":"2542511551","title":"BRIEF-enGene Reports Second Quarter 2025 Financial Results And Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2542511551","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542511551?lang=en_us&edition=fundamental","pubTime":"2025-06-12 20:25","pubTimestamp":1749731115,"startTime":"0","endTime":"0","summary":"BRIEF-enGene Reports Second Quarter 2025 Financial Results And Provides Business UpdateJune 12 (Reuters) - enGene Holdings Inc ENGN.O:ENGENE REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nTUA1DTDNQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2542519753","title":"enGene Holdings Q2 EPS $(0.51) Misses $(0.49) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2542519753","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542519753?lang=en_us&edition=fundamental","pubTime":"2025-06-12 20:13","pubTimestamp":1749730405,"startTime":"0","endTime":"0","summary":"enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.49) by 4.08 percent. This is a 34.21 percent decrease over losses of $(0.38) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/06/45902228/engene-holdings-q2-eps-0-51-misses-0-49-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN"],"gpt_icon":0},{"id":"2542199475","title":"enGene Holdings Reports Q2 2025 Net Loss of $25.8M, EPS at $0.51, Up from $15.0M Loss, EPS $0.38 in Q2 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2542199475","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542199475?lang=en_us&edition=fundamental","pubTime":"2025-06-12 20:01","pubTimestamp":1749729697,"startTime":"0","endTime":"0","summary":"enGene Holdings Inc. , a clinical-stage, non-viral genetic medicines company, has released its financial results for the second quarter ended April 30, 2025. The company reported a net loss attributable to common shareholders of approximately $25.8 million, or $0.51 per share. This reflects an increase from the net loss of about $15.0 million, or $0.38 per share, recorded in the same period the previous year. The increase in net loss is mainly due to higher operating expenses, partially offset by net interest income. The company remains on track for its Biologics License Application  filing for mid-2026, with additional preliminary data from the ongoing LEGEND study anticipated in the second half of 2025. enGene also completed the European Medicines Agency  Scientific Advice process, indicating that the data could support a Conditional Marketing Authorization Application for detalimogene in BCG-unresponsive NMIBC with CIS, assuming a positive benefit-risk ratio. Additionally, enGene an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL51K12H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"enGene Holdings Reports Q2 2025 Net Loss of $25.8M, EPS at $0.51, Up from $15.0M Loss, EPS $0.38 in Q2 2024","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN"],"gpt_icon":0},{"id":"2542151963","title":"Press Release: enGene Reports Second Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2542151963","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542151963?lang=en_us&edition=fundamental","pubTime":"2025-06-12 20:00","pubTimestamp":1749729600,"startTime":"0","endTime":"0","summary":"Additional preliminary data from ongoing LEGEND study of detalimogene in pivotal cohort of BCG-unresponsive NMIBC with CIS anticipated in 2H 2025. Biologics License Application  filing planned for mid-2026 remains on track. EMA Scientific Advice completed; Indicated data could be suitable for a Contingent Marketing Authorization Application. Cash and marketable securities of $251.5 million expected to provide runway into 2027. enGene Holdings Inc. , a clinical-stage, non-viral genetic medicines company, today announced its financial results for the second quarter ended April 30, 2025, and provided a business update.\"We have seen strong enrollment in the pivotal cohort of our LEGEND study,\" said Ron Cooper, Chief Executive Officer of enGene. \"This positions us to stay on track for our planned trial updates across all cohorts in the second half of 2025 and a potential BLA filing in mid-2026, advancing our goal to introduce a novel, non-viral therapy that could redefine treatment for pati","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMA","CMA","BCG","BK4139","BK4207","BK4022","ENGN","BK4211","BK4135","BK4585","BK4232","BK4588","BK4589","BK4081","R"],"gpt_icon":0},{"id":"2542590985","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2542590985","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542590985?lang=en_us&edition=fundamental","pubTime":"2025-06-12 18:00","pubTimestamp":1749722400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Beyond Air Inc.                                 4Q      (.12)  4:05 PM. ·Aurora Cannabis Inc.                             4Q       .09   7:00 AM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0081259029.USD","RNW","CRMT","LU0157215616.USD","SG9999014914.USD","LU0823414478.USD","BK4567","BK4588","LOVE","IE00BFXG0V08.USD","LU0672654240.SGD","LU0511384066.AUD","BK4133","LU2236285917.USD","LEN","AMC","LU1366333091.USD","LU2095319765.USD","GMS","BK4566","SG9999014898.SGD","BK4095","LU2210149790.SGD","LU2125154778.USD","BK4596","LU2458330243.SGD","BK4108","LU0069063385.USD","BK4516","ADBE","LU1235294995.USD","KFY","LU0557290698.USD","LU0719512351.SGD","BK4007","IE00B5TLWC47.USD","LU0061474960.USD","LU2317271919.USD","BK4157","LZB","ENGN","LEN.B","JBL","AIOT","LU1861220033.SGD","ACB","BK4543","RH","XAIR","BK4214"],"gpt_icon":1},{"id":"2542328641","title":"enGene Holdings Inc. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542328641","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542328641?lang=en_us&edition=fundamental","pubTime":"2025-06-11 05:27","pubTimestamp":1749590827,"startTime":"0","endTime":"0","summary":"enGene Holdings Inc. held its Annual General Meeting on June 10, 2025. Shareholders approved the election of Gerald Brunk and Dr. Richard Glickman as directors. The 2025 Employee Stock Purchase Plan was also approved, allowing eligible employees to acquire a proprietary interest in the company. Additionally, the appointment and remuneration of the auditor were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL9yrmFj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2542388717","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2542388717","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542388717?lang=en_us&edition=fundamental","pubTime":"2025-06-09 18:00","pubTimestamp":1749463200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Dave & Buster's Ent                             1Q      1.01       AMC. ·Gitlab Inc. Class A                             1Q       .15       AMC. ·J.M. Smucker Co                                  4Q      2.24   7:00 AM. ·Stitch Fix Inc.                                 3Q      (.12)  4:05 PM. ·Chewy Inc. Class A                              1Q       .17   7:05 AM. ·Oxford Indus Inc.                                1Q      1.82   4:05 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHWY","BK4533","ADBE","LU0234570918.USD","LU0289961442.SGD","LAKE","SAIL","SGXZ81514606.USD","ENGN","ORCL","GHM","BK4561","IE00BN8TJ469.HKD","LU0130517989.USD","VSCO","LOVE","LU2125910179.SGD","UNFI","LU2360106780.USD","OXM","CASY","GTLB","SFIX","JILL","DBI","AMC","LU1435385759.SGD","BK4551","LU2357305700.SGD","VFS","RH","LU0942090050.USD","LU2089283258.USD","LU2458330243.SGD","AII","LU0878866978.SGD","SJM","PLAY","CMTL","CRMT","KR","LU0965509283.SGD","CNM","LU1935042215.USD","BK4122","BK4547","IE0002270589.USD","ASO","CVGW","LU1506573853.SGD"],"gpt_icon":1},{"id":"2542387622","title":"enGene Holdings Inc  expected to post a loss of 50 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2542387622","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542387622?lang=en_us&edition=fundamental","pubTime":"2025-06-09 11:02","pubTimestamp":1749438171,"startTime":"0","endTime":"0","summary":"enGene Holdings Inc  expected to post a loss of50cents a share - Earnings Preview enGene Holdings Inc ENGN.OQ ENGN.O is expected to show no change in quarterly revenue when it reports  results on June","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nL8N3SC01H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"enGene Holdings Inc  expected to post a loss of 50 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN"],"gpt_icon":0},{"id":"2540906510","title":"enGene Holdings Inc. Announces Resignation of Chief Medical Officer Dr. Raj Pruthi, Effective June 16, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2540906510","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540906510?lang=en_us&edition=fundamental","pubTime":"2025-06-04 20:30","pubTimestamp":1749040221,"startTime":"0","endTime":"0","summary":"enGene Holdings Inc., a clinical-stage genetic medicines company, announced that Dr. Raj Pruthi will resign from his position as Chief Medical Officer, effective June 16, 2025. The company plans to redistribute his responsibilities among its existing urology and clinical experts.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Holdings Inc. published the original content used to generate this news brief via Business Wire  on June 04, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL80TxQM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2539299625","title":"enGene Holdings Inc. Files Initial Statement of Beneficial Ownership for Chief Global Communications Officer Amy Pott","url":"https://stock-news.laohu8.com/highlight/detail?id=2539299625","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539299625?lang=en_us&edition=fundamental","pubTime":"2025-05-30 05:31","pubTimestamp":1748554286,"startTime":"0","endTime":"0","summary":"enGene Holdings Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing lists Amy Pott as the beneficial owner, serving in the role of Chief Global Communications Officer. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL3yPfZ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2539425772","title":"enGene Holdings Inc. to Present at Jefferies Global Healthcare Conference in New York City","url":"https://stock-news.laohu8.com/highlight/detail?id=2539425772","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539425772?lang=en_us&edition=fundamental","pubTime":"2025-05-29 20:00","pubTimestamp":1748520041,"startTime":"0","endTime":"0","summary":"enGene Holdings Inc., a clinical-stage non-viral genetic medicines company, will present at the Jefferies Global Healthcare Conference in New York City. The presentation by CEO Ron Cooper is scheduled for Wednesday, June 4, 2025, at 11:05 a.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Holdings Inc. published the original content used to generate this news brief via Business Wire  on May 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL8WxG4k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-06-12","symbol":"ENGN","fiscalQuarterEnding":"2025/04","expectedEps":-0.5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1749700800000,"reportTimeType":"pre","actualEps":-0.51},{"market":"US","date":"2025-03-10","symbol":"ENGN","fiscalQuarterEnding":"2025/01","expectedEps":-0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2024-12-19","symbol":"ENGN","fiscalQuarterEnding":"2024/10","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1734584400000,"reportTimeType":"post","actualEps":-0.34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.5455,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1739851200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ENGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ENGN","date":"2025-08-01","current":-2.424807,"percent":0.839109,"low":-11.074501,"twenty":-6.646743,"median":-3.5204,"eighty":-2.507148,"high":-1.741293,"avg":-4.403457,"sd":1.968874,"marketCap":193688711},"quantilePoints":[{"date":"2023-11-24","current":-7.107113,"twenty":-7.362609,"median":-7.152095,"eighty":-7.017149,"marketCap":183264010},{"date":"2023-12-01","current":-6.8912,"twenty":-7.362609,"median":-7.170087,"eighty":-7.020748,"marketCap":177696496},{"date":"2023-12-08","current":-6.666292,"twenty":-8.564557,"median":-7.174585,"eighty":-6.887602,"marketCap":171897002},{"date":"2023-12-15","current":-6.641012,"twenty":-7.798032,"median":-7.107113,"eighty":-6.607942,"marketCap":171245139},{"date":"2023-12-22","current":-6.504358,"twenty":-7.362609,"median":-6.814731,"eighty":-6.515153,"marketCap":167721366},{"date":"2023-12-29","current":-7.296036,"twenty":-7.276244,"median":-6.747259,"eighty":-6.432387,"marketCap":188135585},{"date":"2024-01-05","current":-6.405398,"twenty":-7.70447,"median":-6.814731,"eighty":-6.412595,"marketCap":165169589},{"date":"2024-01-12","current":-7.251054,"twenty":-7.438178,"median":-6.882204,"eighty":-6.486365,"marketCap":186975686},{"date":"2024-01-19","current":-7.197076,"twenty":-7.362609,"median":-6.882204,"eighty":-6.515153,"marketCap":185583808},{"date":"2024-01-26","current":-6.837222,"twenty":-7.314029,"median":-6.823728,"eighty":-6.515153,"marketCap":176304617},{"date":"2024-02-02","current":-1.959536,"twenty":-7.276604,"median":-6.810233,"eighty":-6.462974,"marketCap":195790917},{"date":"2024-02-09","current":-1.845771,"twenty":-7.256092,"median":-6.76975,"eighty":-6.369412,"marketCap":184423909},{"date":"2024-02-16","current":-3.645108,"twenty":-7.218667,"median":-6.747259,"eighty":-3.756551,"marketCap":364208223},{"date":"2024-02-23","current":-6.848243,"twenty":-7.197076,"median":-6.729266,"eighty":-3.686899,"marketCap":684255939},{"date":"2024-03-01","current":-6.376994,"twenty":-7.189879,"median":-6.715257,"eighty":-3.782089,"marketCap":637170146},{"date":"2024-03-08","current":-6.913094,"twenty":-7.175485,"median":-6.740159,"eighty":-4.788696,"marketCap":690735636},{"date":"2024-03-15","current":-7.043277,"twenty":-7.155487,"median":-6.747259,"eighty":-6.236267,"marketCap":726936601},{"date":"2024-03-22","current":-7.516207,"twenty":-7.197076,"median":-6.792241,"eighty":-6.288445,"marketCap":775747691},{"date":"2024-03-28","current":-7.279742,"twenty":-7.276523,"median":-6.837222,"eighty":-6.349337,"marketCap":751342146},{"date":"2024-04-05","current":-6.925044,"twenty":-7.26113,"median":-6.876032,"eighty":-6.379076,"marketCap":714733828},{"date":"2024-04-12","current":-6.874373,"twenty":-7.240258,"median":-6.870151,"eighty":-6.391004,"marketCap":709504068},{"date":"2024-04-19","current":-5.983407,"twenty":-7.197076,"median":-6.842733,"eighty":-6.391004,"marketCap":617547460},{"date":"2024-04-26","current":-6.289752,"twenty":-7.193478,"median":-6.810233,"eighty":-6.342947,"marketCap":649165336},{"date":"2024-05-03","current":-6.546128,"twenty":-7.177285,"median":-6.792241,"eighty":-6.351434,"marketCap":675625879},{"date":"2024-05-10","current":-6.153019,"twenty":-7.167527,"median":-6.747259,"eighty":-6.342947,"marketCap":635053046},{"date":"2024-05-17","current":-6.063287,"twenty":-7.153064,"median":-6.743709,"eighty":-6.259918,"marketCap":625791856},{"date":"2024-05-24","current":-5.614629,"twenty":-7.135657,"median":-6.708499,"eighty":-6.098325,"marketCap":579485904},{"date":"2024-05-31","current":-4.486576,"twenty":-7.133587,"median":-6.688278,"eighty":-6.063287,"marketCap":463059513},{"date":"2024-06-07","current":-3.360659,"twenty":-7.131951,"median":-6.661794,"eighty":-5.648813,"marketCap":346853625},{"date":"2024-06-14","current":-4.27293,"twenty":-7.118439,"median":-6.651549,"eighty":-5.484732,"marketCap":441009060},{"date":"2024-06-21","current":-3.406965,"twenty":-7.110292,"median":-6.643683,"eighty":-5.017274,"marketCap":384687244},{"date":"2024-06-28","current":-3.508666,"twenty":-7.107113,"median":-6.634163,"eighty":-4.27293,"marketCap":396170446},{"date":"2024-07-05","current":-3.516489,"twenty":-7.107113,"median":-6.621073,"eighty":-3.815858,"marketCap":397053769},{"date":"2024-07-12","current":-3.5204,"twenty":-7.093203,"median":-6.587237,"eighty":-3.642484,"marketCap":397495431},{"date":"2024-07-15","current":-3.547781,"twenty":-7.089725,"median":-6.572786,"eighty":-3.63199,"marketCap":400587062},{"date":"2024-08-02","current":-3.446081,"twenty":-7.089604,"median":-6.558336,"eighty":-3.589657,"marketCap":389103860},{"date":"2024-08-09","current":-2.777205,"twenty":-7.088397,"median":-6.52142,"eighty":-3.527005,"marketCap":313579728},{"date":"2024-08-16","current":-2.307818,"twenty":-7.080829,"median":-6.504358,"eighty":-3.517271,"marketCap":260580338},{"date":"2024-08-23","current":-2.370403,"twenty":-7.05836,"median":-6.454878,"eighty":-3.458598,"marketCap":267646923},{"date":"2024-08-30","current":-2.573804,"twenty":-7.039722,"median":-6.405398,"eighty":-3.383305,"marketCap":290613326},{"date":"2024-09-06","current":-2.554246,"twenty":-7.025502,"median":-6.379484,"eighty":-3.290156,"marketCap":288405018},{"date":"2024-09-13","current":-2.400727,"twenty":-6.984161,"median":-6.343733,"eighty":-3.031456,"marketCap":293704957},{"date":"2024-09-20","current":-2.587735,"twenty":-6.954602,"median":-6.302571,"eighty":-2.628566,"marketCap":316583531},{"date":"2024-09-27","current":-1.987785,"twenty":-6.936182,"median":-6.238965,"eighty":-2.585538,"marketCap":243185673},{"date":"2024-10-04","current":-2.349201,"twenty":-6.925044,"median":-6.153019,"eighty":-2.573804,"marketCap":287401250},{"date":"2024-10-11","current":-2.479311,"twenty":-6.921741,"median":-6.080379,"eighty":-2.554246,"marketCap":303318858},{"date":"2024-10-18","current":-3.361165,"twenty":-6.921741,"median":-5.983407,"eighty":-2.554246,"marketCap":411204866},{"date":"2024-10-25","current":-3.216598,"twenty":-6.91854,"median":-5.659496,"eighty":-2.56605,"marketCap":393518635},{"date":"2024-10-31","current":-3.137087,"twenty":-6.914183,"median":-5.580446,"eighty":-2.572253,"marketCap":383791208},{"date":"2024-11-08","current":-3.035891,"twenty":-6.895579,"median":-5.443712,"eighty":-2.573804,"marketCap":371410846},{"date":"2024-11-15","current":-3.304095,"twenty":-6.884003,"median":-4.928824,"eighty":-2.580062,"marketCap":404222931},{"date":"2024-11-22","current":-3.195938,"twenty":-6.875939,"median":-4.2302,"eighty":-2.584756,"marketCap":390991104},{"date":"2024-11-29","current":-3.604285,"twenty":-6.87184,"median":-3.830846,"eighty":-2.585538,"marketCap":440948247},{"date":"2024-12-06","current":-3.600118,"twenty":-6.869976,"median":-3.719091,"eighty":-2.585538,"marketCap":440438480},{"date":"2024-12-13","current":-2.745924,"twenty":-6.85689,"median":-3.63199,"eighty":-2.586856,"marketCap":335936294},{"date":"2024-12-20","current":-2.483415,"twenty":-6.84163,"median":-3.604285,"eighty":-2.585538,"marketCap":303820988},{"date":"2024-12-27","current":-5.676196,"twenty":-6.836881,"median":-3.618138,"eighty":-2.585538,"marketCap":312996790},{"date":"2025-01-03","current":-6.526701,"twenty":-6.831143,"median":-3.666853,"eighty":-2.585977,"marketCap":359895332},{"date":"2025-01-10","current":-7.488141,"twenty":-6.86986,"median":-3.752745,"eighty":-2.587735,"marketCap":412911075},{"date":"2025-01-17","current":-6.480478,"twenty":-6.874373,"median":-4.2302,"eighty":-2.598578,"marketCap":357346498},{"date":"2025-01-24","current":-6.739327,"twenty":-6.870995,"median":-4.27293,"eighty":-2.60436,"marketCap":371619968},{"date":"2025-01-31","current":-6.563679,"twenty":-6.869918,"median":-5.380342,"eighty":-2.617897,"marketCap":361934399},{"date":"2025-02-07","current":-5.870333,"twenty":-6.868974,"median":-5.443712,"eighty":-2.624253,"marketCap":323701892},{"date":"2025-02-14","current":-5.777887,"twenty":-6.852345,"median":-5.580446,"eighty":-2.62701,"marketCap":318604225},{"date":"2025-02-21","current":-5.657707,"twenty":-6.84163,"median":-5.580446,"eighty":-2.628136,"marketCap":311977257},{"date":"2025-02-28","current":-5.398857,"twenty":-6.836711,"median":-5.546263,"eighty":-2.689586,"marketCap":297703787},{"date":"2025-03-07","current":-4.908892,"twenty":-6.833612,"median":-5.507012,"eighty":-2.739661,"marketCap":270686149},{"date":"2025-03-14","current":-3.949849,"twenty":-6.818849,"median":-5.443712,"eighty":-2.748264,"marketCap":272725216},{"date":"2025-03-21","current":-3.846555,"twenty":-6.800468,"median":-5.398857,"eighty":-2.766253,"marketCap":265593087},{"date":"2025-03-28","current":-3.506936,"twenty":-6.792928,"median":-5.371072,"eighty":-2.784959,"marketCap":242143410},{"date":"2025-04-04","current":-3.32236,"twenty":-6.792241,"median":-5.209343,"eighty":-2.829161,"marketCap":229399020},{"date":"2025-04-11","current":-2.953209,"twenty":-6.790707,"median":-4.908892,"eighty":-2.913999,"marketCap":203910240},{"date":"2025-04-17","current":-2.923677,"twenty":-6.772715,"median":-4.84418,"eighty":-2.93549,"marketCap":201871137},{"date":"2025-04-25","current":-2.953209,"twenty":-6.747259,"median":-4.251565,"eighty":-2.945826,"marketCap":203910240},{"date":"2025-05-02","current":-2.761251,"twenty":-6.747259,"median":-3.986833,"eighty":-2.932537,"marketCap":190656074},{"date":"2025-05-09","current":-2.502845,"twenty":-6.744419,"median":-3.927701,"eighty":-2.802203,"marketCap":172813928},{"date":"2025-05-16","current":-2.510228,"twenty":-6.739826,"median":-3.830846,"eighty":-2.747484,"marketCap":173323704},{"date":"2025-05-23","current":-3.167317,"twenty":-6.735303,"median":-3.794841,"eighty":-2.747484,"marketCap":218693732},{"date":"2025-05-30","current":-2.923677,"twenty":-6.725113,"median":-3.752745,"eighty":-2.752109,"marketCap":201871137},{"date":"2025-06-06","current":-2.672654,"twenty":-6.707049,"median":-3.661979,"eighty":-2.752109,"marketCap":184538767},{"date":"2025-06-13","current":-2.07932,"twenty":-6.698654,"median":-3.63591,"eighty":-2.725522,"marketCap":166091903},{"date":"2025-06-20","current":-2.104911,"twenty":-6.688278,"median":-3.604285,"eighty":-2.672654,"marketCap":168136111},{"date":"2025-06-27","current":-2.296849,"twenty":-6.667466,"median":-3.604285,"eighty":-2.62092,"marketCap":183467671},{"date":"2025-07-03","current":-2.431205,"twenty":-6.666527,"median":-3.583451,"eighty":-2.587296,"marketCap":194199763},{"date":"2025-07-11","current":-2.35443,"twenty":-6.659095,"median":-3.561833,"eighty":-2.580062,"marketCap":188067139},{"date":"2025-07-18","current":-2.35443,"twenty":-6.655298,"median":-3.539958,"eighty":-2.554246,"marketCap":188067139},{"date":"2025-07-25","current":-2.360828,"twenty":-6.649599,"median":-3.52355,"eighty":-2.534434,"marketCap":188578191},{"date":"2025-08-01","current":-2.424807,"twenty":-6.646743,"median":-3.5204,"eighty":-2.507148,"marketCap":193688711}],"updateTime":1754148314942}}}